Medibio: Raises $3.5M via placement and SPP

  • Health technology company Medibio (MEB) plans to raise up to $3.5 million through a capital raise and share purchase plan
  • The company has received commitments for a $3 million placement of around 333.3 million new fully paid ordinary shares
  • Medibio will offer investors one free attaching option for every four new shares issued at 1.5 cents per option
  • Medibio will also conduct a $500,000 share purchase plan, which expected to fully underwritten
  • Proceeds will fund a depressive burden trial, MEBsleep and ilumen product commercialisation activities and consumer app development
  • Medibio is up 11.11 per cent and trading at 1 cent per share
Steve Sam
Steve Sam
Steve Sam is a financial reporter, analyst, and commentator with a strong focus on banking technology, digital payments, and the future of financial services.

You May Also Like

Swedish Central Bank Tightens Actions on Banks Over Instant Payments

The central bank of Sweden warns banks on instant payment compliance. Highlights: Swedish Central Bank warns banks about compliance...

India’s PhonePe Pauses IPO Amid Geopolitical Tensions

PhonePe's IPO delay highlights market uncertainties due to global issues. Highlights: PhonePe has postponed its IPO indefinitely.The decision stems...

Ramp Acquires Billhop to Expand into EU and UK Markets

Ramp aims for broader payment solutions and market reach through acquisition. Highlights: Ramp has acquired Billhop, focusing on expanding...

Chaseitai Launches AI Agents for Call Center Loan Servicing

New AI technology aims to enhance customer service in fintech. Highlights: Chaseitai introduces AI agents for call center support.New...